Cohen, Robert M.

DOPA Decarboxylase Activity in Attention Deficit Hyperactivity Disorder Adults. A [Fluorine-18]Fluorodopa Positron Emission Tomographic Study

Ernst, M., Zametkin, A. J., Matochik, J. A., Jons, P. H., & Cohen, R. M. (1998) · The Journal of Neuroscience

Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior

Cited by 320

Effects of Acute Stimulant Medication on Cerebral Metabolism in Adults with Hyperactivity

Matochik, J. A., Nordahl, T. E., Gross, M., Semple, W. E., King, A. C., Cohen, R. M., & Zametkin, A. J. (1993) · Neuropsychopharmacology

Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior

Cited by 105

Incorporating multidimensional patient-reported outcomes of symptom severity, functioning, and quality of life in the Individual Burden of Illness Index for Depression to measure treatment impact and recovery in MDD

Cohen, R. M., Greenberg, J. M., & IsHak, W. W. (2013) · JAMA Psychiatry

Health Systems, Economic Evaluations, Quality of LifeAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 86

Patient-reported functioning in major depressive disorder

IsHak, W. W., James, D. M., Mirocha, J., Youssef, H., Tobia, G., Pi, S., Collison, K. L., & Cohen, R. M. (2016) · Therapeutic Advances in Chronic Disease

Treatment of Major DepressionMental Health Treatment and Access

Cited by 71